Literature DB >> 22505655

p53 N-terminal phosphorylation: a defining layer of complex regulation.

Lisa M Miller Jenkins1, Stewart R Durell, Sharlyn J Mazur, Ettore Appella.   

Abstract

The p53 tumor suppressor is a critical component of the cellular response to stress. As it can inhibit cell growth, p53 is mutated or functionally inactivated in most tumors. A multitude of protein-protein interactions with transcriptional cofactors are central to p53-dependent responses. In its activated state, p53 is extensively modified in both the N- and C-terminal regions of the protein. These modifications, especially phosphorylation of serine and threonine residues in the N-terminal transactivation domain, affect p53 stability and activity by modulating the affinity of protein-protein interactions. Here, we review recent findings from in vitro and in vivo studies on the role of p53 N-terminal phosphorylation. These modifications can either positively or negatively affect p53 and add a second layer of complex regulation to the divergent interactions of the p53 transactivation domain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22505655      PMCID: PMC3499055          DOI: 10.1093/carcin/bgs145

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  87 in total

Review 1.  Regulation of p53 function.

Authors:  D B Woods; K H Vousden
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

2.  Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain.

Authors:  Grzegorz M Popowicz; Anna Czarna; Tad A Holak
Journal:  Cell Cycle       Date:  2008-05-27       Impact factor: 4.534

3.  Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47.

Authors:  Karima Bourougaa; Nadia Naski; Cedric Boularan; Coraline Mlynarczyk; Marco M Candeias; Stefano Marullo; Robin Fåhraeus
Journal:  Mol Cell       Date:  2010-04-09       Impact factor: 17.970

Review 4.  p53: exercise capacity and metabolism.

Authors:  Ping-Yuan Wang; Jie Zhuang; Paul M Hwang
Journal:  Curr Opin Oncol       Date:  2012-01       Impact factor: 3.645

5.  Binding of p53 to the KIX domain of CREB binding protein. A potential link to human T-cell leukemia virus, type I-associated leukemogenesis.

Authors:  K Van Orden; H A Giebler; I Lemasson; M Gonzales; J K Nyborg
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

6.  Nitration of the tumor suppressor protein p53 at tyrosine 327 promotes p53 oligomerization and activation.

Authors:  Vasily A Yakovlev; Alexander S Bayden; Paul R Graves; Glen E Kellogg; Ross B Mikkelsen
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

7.  Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.

Authors:  Hanqiao Feng; Lisa M Miller Jenkins; Stewart R Durell; Ryo Hayashi; Sharlyn J Mazur; Scott Cherry; Joseph E Tropea; Maria Miller; Alexander Wlodawer; Ettore Appella; Yawen Bai
Journal:  Structure       Date:  2009-02-13       Impact factor: 5.006

8.  HCMV IE2-mediated inhibition of HAT activity downregulates p53 function.

Authors:  Chih-Hung Hsu; Margaret D T Chang; Kang-Yu Tai; Yu-Ting Yang; Pei-Shan Wang; Chi-Ju Chen; Yan-Hsiung Wang; Sheng-Chung Lee; Cheng-Wen Wu; Li-Jung Juan
Journal:  EMBO J       Date:  2004-05-13       Impact factor: 11.598

9.  Serine 15 phosphorylation of p53 directs its interaction with B56gamma and the tumor suppressor activity of B56gamma-specific protein phosphatase 2A.

Authors:  Geoffrey P Shouse; Xin Cai; Xuan Liu
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

10.  Loss of p53 Ser18 and Atm results in embryonic lethality without cooperation in tumorigenesis.

Authors:  Heather L Armata; Punita Shroff; David E Garlick; Krista Penta; Andrew R Tapper; Hayla K Sluss
Journal:  PLoS One       Date:  2011-09-27       Impact factor: 3.240

View more
  44 in total

1.  Unbiased selective isolation of protein N-terminal peptides from complex proteome samples using phospho tagging (PTAG) and TiO(2)-based depletion.

Authors:  Geert P M Mommen; Bas van de Waterbeemd; Hugo D Meiring; Gideon Kersten; Albert J R Heck; Ad P J M de Jong
Journal:  Mol Cell Proteomics       Date:  2012-06-22       Impact factor: 5.911

Review 2.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

3.  Characterization of the p300 Taz2-p53 TAD2 complex and comparison with the p300 Taz2-p53 TAD1 complex.

Authors:  Lisa M Miller Jenkins; Hanqiao Feng; Stewart R Durell; Harichandra D Tagad; Sharlyn J Mazur; Joseph E Tropea; Yawen Bai; Ettore Appella
Journal:  Biochemistry       Date:  2015-03-16       Impact factor: 3.162

4.  Converging Mechanisms of p53 Activation Drive Motor Neuron Degeneration in Spinal Muscular Atrophy.

Authors:  Christian M Simon; Ya Dai; Meaghan Van Alstyne; Charalampia Koutsioumpa; John G Pagiazitis; Joshua I Chalif; Xiaojian Wang; Joseph E Rabinowitz; Christopher E Henderson; Livio Pellizzoni; George Z Mentis
Journal:  Cell Rep       Date:  2017-12-26       Impact factor: 9.423

5.  Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer.

Authors:  D Ashikari; K Takayama; T Tanaka; Y Suzuki; D Obinata; T Fujimura; T Urano; S Takahashi; S Inoue
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

Review 6.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

7.  A Novel Role for Pyruvate Kinase M2 as a Corepressor for P53 during the DNA Damage Response in Human Tumor Cells.

Authors:  Li Xia; Xin-Ran Wang; Xiao-Ling Wang; Su-Hui Liu; Xiao-Wei Ding; Guo-Qiang Chen; Ying Lu
Journal:  J Biol Chem       Date:  2016-11-03       Impact factor: 5.157

8.  Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.

Authors:  Alexander S Krois; Josephine C Ferreon; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

9.  Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia.

Authors:  Nilesh K Sharma; Maria Lebedeva; Terace Thomas; Olga A Kovalenko; Jeffrey D Stumpf; Gerald S Shadel; Janine H Santos
Journal:  DNA Repair (Amst)       Date:  2013-12-15

10.  Unravelling mechanisms of p53-mediated tumour suppression.

Authors:  Kathryn T Bieging; Stephano Spano Mello; Laura D Attardi
Journal:  Nat Rev Cancer       Date:  2014-04-17       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.